Squalene synthase inhibitors are research reagents that target the enzyme squalene synthase, a critical component in the mevalonate pathway for cholesterol biosynthesis. These compounds facilitate investigations into lipid metabolism regulation and potential interventions for metabolic and cardiovascular conditions.